Advertisement

Immunological Investigation of Thymic-Dependent Immunity in Normal Aging and in Patients with Senile Dementia of Alzheimer Type

  • Giancarlo Savorani
  • Gabriele Sarti
  • Afro Salsi
  • Francesco Cavazzuti
  • Lucio Zanichelli
  • Giuseppe Tucci
  • Eugenio Mocchegiani
  • Nicola Fabris
  • Mariella Chiricolo
  • Federico Licastro
Conference paper
Part of the GWUMC Department of Biochemistry Annual Spring Symposia book series (GWUN)

Abstract

Alzheimer’s disease (AD) is a primary degenerative and progressive form of dementia with an insidious onset (Amaducci and Sorbi, 1985; Gottfries, 1985). With advancing age, an increasing prevalence of AD has been observed. In industrialized countries, approximately 6% of people over 65 years, 22% of those over 80 years, and 40% of the elderly over 90 years of age are affected by this debilitating illness (Henderson, 1986).

Keywords

Peripheral Blood Lymphocyte Alzheimer Type Senile Dementia Suppressor Cell Activity Normal Elderly Subject 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Amaducci, L., and Sorbi, S., 1985, L’invecchiamento cerebrale: Definizione ed inquadramento nosologico, G. Gerontol. 33: 1033–1054.Google Scholar
  2. Amaducci, L. A., Fratiglioni, L., Rocca, W., Fieschi, C., Livrea, P., Pedone, D., Bracco, L., Lippi, A., Gandolfo, C., Bino, G., Prencipe, M., Bonatti, M., Girotti, F., Carella, F., Tavolato, B., Feria, S., Lenzi, G. L., Carolei, A., Gambi, A., Grigoletto, F., and Schoenberg, B., 1986, Risk factors for clinically diagnosed Alzheimer’s disease: A case-control study for an Italian population, Neurology (NY) 36: 922–931.Google Scholar
  3. American Psychiatric Association, 1980, Diagnostic and Statistical Manual of Mental Disorders, 3rd ed., American Psychiatric Association, Washington, D.C.Google Scholar
  4. Behan, P. O., and Feldman, R. G., 1970, Serum protein, amyloid and Alzheimer’s disease, J. Am. Geriatr. Soc. 18: 792–797.PubMedGoogle Scholar
  5. Boyum, 1968, Separation of leukocytes from blood and bone marrow, Scand. J. Clin. Lab. Invest. 21 (suppl. 97): 77–89.Google Scholar
  6. Chandra, V., Bharucha, N. E., and Schoenberg, B. S., 1986, Conditions associated with Alzheimer’s disease at death: Case-control study, Neurology (NY) 36: 209–211.Google Scholar
  7. Dardenne, M., Pleau, J. M., Nabama, B., Lefancier, P., Denierr, P., Chosy, M., and Bach, J. F., 1982, Contributions of zinc and other metal to the biological activity of serum thymic factor, Proc. Natl. Acad. Sci. USA 79: 5370–5373.PubMedCrossRefGoogle Scholar
  8. Fabris, N., Mocchegiani, E., Amadio, L., Zannotti, M., Licastro, F., and Franceschi, C., 1984, Thymic hormone deficiency in normal ageing and Down’s syndrome: Is there a primary failure of the thymus?, Lancet 1: 983–986.PubMedCrossRefGoogle Scholar
  9. Folstein, M., Folstein, S., and McHugh, P. R., 1975, Mini Mental state: A practical method for grading the cognitive state of patients for the clinician, J. Psychiatr. Res. 12: 189–198.PubMedCrossRefGoogle Scholar
  10. Forte, P. L., Crimi, G., and Beltramello, A., 1988, Correlazioni cliniche, neuropsicologiche e neuroradiologiche nella involuzione cerebrale senile, G. Gerontol. 36: 45–57.Google Scholar
  11. Franceschi, C., Licastro, F., Chiricolo, M., Bonetti, F., Zannotti, M., Fabris, N., Mocchegiani, E., Fantini, M. P., Paolucci, P., and Masi, M., 1981, Deficiency of autologous mixed lymphocyte reactions and serum thymic factor level in Down’s syndrome, J. Immunol. 126: 2161–2164.PubMedGoogle Scholar
  12. Fudenbergh, H. H., Whitten, H. D., Arnaud, P., and Khansari, N., 1984, Is Alzheimer’s disease an immunological disorder? Observations and speculations, Clin. Immunol. Immunopathol. 32: 127–131.CrossRefGoogle Scholar
  13. Gaskin, F., Kingsley, B. S., and Fu, S. M., 1987, Autoantibodies to neurofibrillary tangles and brain tissue in Alzheimer’s disease, J. Exp. Med, 165: 245–250.PubMedCrossRefGoogle Scholar
  14. Gottfries, C. G., 1985, Definition of normal ageing senile dementia and Alzheimer’s disease, in Normal Ageing, Alzheimer’s Disease and Senile Dementia ( G. G. Gottfries ed.), Editions Université Bruxelles, Brussels, pp. 11–17.Google Scholar
  15. Hachinski, V. C., Iliff, L. D., Zilhka, E., Dubolay, G. H., McAllister, V., Marshall, J., Ross-Russel, R. W., and Symon, L., 1975, Cerebral blood flow in dementia, Arch. Neurol. 32: 632–637.PubMedGoogle Scholar
  16. Henderson, A. S., 1986, The epidemiology of Alzheimer’s disease, Br. Med. Bull. 42: 3–10.PubMedGoogle Scholar
  17. Hollander, E., Mohs, R. C., and Davis, K. L., 1986, Antemortem markers of Alzheimer’s disease, Neurobiol. Aging 7: 367––387.PubMedCrossRefGoogle Scholar
  18. Kalter, S., and Kelly, S., 1975, Alzheimer’s disease: Evaluation of immunological indeces, NY State J. Med. 75: 1222–1225.Google Scholar
  19. Lèffell, M. S., Lumsden, L., and Steiger, W. A., 1985, An analysis of T lymphocyte subpopulations in patients with Alzheimer’s disease, J. Am. Geriatr. Soc. 33: 4–8.PubMedGoogle Scholar
  20. Licastro, F., Chiricolo, M., Tabacchi, L., Barboni, F., Zannotti, M., and Franceschi, C., 1983a, Enhacing effect of lithium and potassium ions on lectin-induced lymphocyte proliferation in ageing and Down’s syndrome subjects, Cell. Immunol. 75: 111–121.PubMedCrossRefGoogle Scholar
  21. Licastro, F., Tabacchi, L., Chiricolo, M., Parente, R., Cenci, M., Barboni, F., and Franceschi, C., 1983b, Defective self-recognition in subjects of far advanced age, Gerontology 29: 64–72.PubMedCrossRefGoogle Scholar
  22. Macdonald, S. M., Goldstone, A. H., Morris, J. E., Exton-Smith, A. N., and Callard, R. E., 1982, Immunological parameters in the aged and in Alzheimer’s disease, Clin, Exp. Immunol. 49: 123–128.Google Scholar
  23. Mayeux, R., Stern, Y., and Spaton, S., 1985, Heterogeneity in dementia of the Alzheimer type: Evidence ofsubgroups, Neurology (NY) 35: 453–461.Google Scholar
  24. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., and Stadlan, E., 1984, Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and human services Task Force on Alzheimer’s disease, Neurology (NY) 34: 939–944.Google Scholar
  25. Miller, A. E., Neighbour, A., Katzman, R., Arouson, M., and Lipkowiz, R., 1981, Immunological studies in senile dementia of the Alzheimer type: Evidence for enhanced suppressor cell activity, Ann. Neurol. 10: 506–510.PubMedCrossRefGoogle Scholar
  26. Nerl, C., Mayeux, R., and O’Neill, G. J., 1984, HLA-linked complement markers in Alzheimer’s and Parkinson’s disease: C variant (C4B2)—a possible marker for senile dementia of the Alzheimer type, Neurology (NY) 34: 310–314.Google Scholar
  27. Pouplard, A., Emile, J., and Vincent-Pineau, F., 1983, Autoanticorps circulants anti cellules à prolectine de l’hipophyse humaine et maladie d’Alzheimer, Rev. Neurol. (Paris) 139: 187–191.Google Scholar
  28. Rossor, M. N., Iversen, L. L., Reynolds, G. P., Mountjoy, C. P., and Roth, M., 1984, Neurochemical characteristics of early and late onset types of Alzheimer’s disease, Br. Med. J. 288: 961–964.CrossRefGoogle Scholar
  29. Roth, M., 1986, The association of clinical and neurological findings and its bearing on the classification and aetiology of Alzheimer’s disease, Br. Med. Bull. 42: 42–50.PubMedGoogle Scholar
  30. Savorani, G., Saisi, A., De vinci, C., Piazzi, S., Sarti, G., Corneli, M., Palmirani, R., Tupone, A., Tolomelli, M., and Cavazzuti, F., 1986, Studies on the possible role of zinc and immune response in Alzheimer’s disease, in: Immunoregulation in Aging EURAGE, 9, ( A. Facchini, J. J. Haaij- mann, and G. Labò, eds.), Rijswijk, The Netherlands, pp. 197–203.Google Scholar
  31. Seltzer, B., and Sherwin, I., 1983, A comparison of clinical features in early and late-onset primary degenerative dementia. One entity or two?, Arch. Neurol. 40: 143–146.PubMedGoogle Scholar
  32. Singh, V. K., Fudenberg, H. H., and Brown, F. R. Ill, 1987, Immunologic dysfunction: Simultaneous study of Alzheimer’s and older Down’s patients, Mech. Ageing Dev. 37: 257–264.CrossRefGoogle Scholar
  33. Skias, D., Bania, M., Reder, A. T., Luchins D., and Antel, J. P., 1985, Senile dementia of Alzheimer type (SDAT): Reduced T6 cell-mediated suppressor activity, Neurology (NY) 35: 1635–1638.Google Scholar
  34. Tavolato, B., and Argentiero, V., 1980, Immunological indices in presenile Alzheimer’s disease, J. Neurol Sci. 46: 325–331.CrossRefGoogle Scholar
  35. Wade, J. P. H., Mirsen, T. R., Hachinski, V. C., Fisman, M., Lau, C., and Merskey, H., 1987, The clinical diagnosis of Alzheimer’s disease, Arch. Neurol. 44: 24–29.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1990

Authors and Affiliations

  • Giancarlo Savorani
    • 1
  • Gabriele Sarti
    • 1
  • Afro Salsi
    • 1
  • Francesco Cavazzuti
    • 1
  • Lucio Zanichelli
    • 1
  • Giuseppe Tucci
    • 1
  • Eugenio Mocchegiani
    • 2
  • Nicola Fabris
    • 2
  • Mariella Chiricolo
    • 3
  • Federico Licastro
    • 3
  1. 1.Department of Geriatric MedicineMalpighi Hospital USL 28BolognaItaly
  2. 2.Gerontology Research DepartmentItalian National Research Center on AgingAnconaItaly
  3. 3.Department of Experimental PathologyUniversity of BolognaBolognaItaly

Personalised recommendations